|
Match
|
Document |
Document Title |
|
|
9034848 |
Phenyl carbamate compounds for use in preventing or treating stroke
A phenyl carbamate compound; a composition for treating and/or preventing stroke containing the phenyl carbamate compound or a pharmaceutically acceptable salt thereof as an active ingredient; a... |
|
|
9028880 |
Silica nanoparticle agent conjugates
The invention provide a silica nanoparticle comprising a non-porous matrix of silicon-oxygen bonds, wherein the matrix comprises organic agents conjugated to silicon or oxygen atoms in the matrix,... |
|
|
9029352 |
Process for the preparation of C-FMS kinase inhibitors
The present invention is directed to a process for the preparation of heterocyclic derivatives of formula I wherein J, X, Z, and R2 are as defined herein. Such compounds are useful as protein... |
|
|
9017650 |
Emulsions of aminofunctional silicones
Aminofunctional silicone emulsions are prepared by forming a mixture of A) 100 parts of a polydialkylsiloxane Having a viscosity of at least 50,000 mm/s at 23° C., and B) 0.1 to 100 parts of an... |
|
|
8999956 |
N-[(het)arylalkyl)] pyrazole(thio)carboxamides and their heterosubstituted analogues
The present invention relates to fungicidal N-[(het)arylalkyl)]pyrazolecarboxamide or thiocarboxamide and their heterosubstituted analogs, their process of preparation and intermediate compounds... |
|
|
8999363 |
Methods and compositions for antimicrobial surfaces
The present invention comprises methods and compositions for treating solid surfaces having antimicrobial and biocidal properties. Such surfaces are capable of controlling or killing a broad... |
|
|
8999955 |
Tetrahydrocyclopenta[c]acridine derivatives as kinase inhibitors and biological
The invention relates to kinase inhibitors of the formula (I) in which —R1 to R4═H; ether or polyether, amino; NO2; NH-carbamate; NH—CO—R, with R such as defined above; N3 and derivatives thereof... |
|
|
8999357 |
Methods and compositions for biocidal treatments
The present invention provides a composition having disinfectancy & residual antimicrobial activity, where the antimicrobial composition comprises an organosilane quaternary compound and a... |
|
|
8999957 |
Heterocyclic compounds as ERK inhibitors
The present invention provides a compound of the Formula I: (Formular I should be inserted here) or a pharmaceutically acceptable salt, solvate or ester thereof, wherein R, R1, R2 and R3 are as... |
|
|
8986722 |
Pest control composition
It is an object of the present invention to provide a pest control composition capable of exerting a high effect on pests such as spider mites and aphids even at low concentration using a... |
|
|
8986741 |
Sunscreen compositions for application to plants
A sunscreen composition for application for plants comprises Titanium Dioxide (TiO2), Zinc Oxide (ZnO), Silicon Dioxide (SiO2), a surfactant, wetting agent, dispersant (SWD) and water. The... |
|
|
8962597 |
Alkyl ketal esters as dispersants and slip agents for particulate solids, methods of manufacture, and uses thereof
Disclosed herein is a dispersion comprising a liquid or semi-solid continuous phase, a dispersed solid phase comprising a plurality of organic, inorganic or inorganic-organic particles, and an... |
|
|
8962596 |
5,7-substituted-imidazo[1,2-C]pyrimidines as inhibitors of JAK kinases
Compounds of Formula I: and stereoisomers and pharmaceutically acceptable salts and solvates thereof in which R1, R2, R3, R4, R5, R6, R7, X1 and X2 have the meanings given in the specification,... |
|
|
8956665 |
Stable aqueous solutions of silane quat ammonium compounds
Stable aqueous compositions of silane quaternary ammonium compounds are provided by diluting an alkanol solution of the silane quaternary ammonium compound in water with at least one nonionic... |
|
|
8946121 |
Antifungal compositions
The present invention relates to new antifungal compositions and their use in the treatment of agricultural products. |
|
|
8937053 |
Process for the preparation of prasugrel and several novel crystalline forms of prasugrel hydrochloride
Disclosed herein are a process or method for the preparation of prasugrel and several novel crystalline forms of prasugrel hydrochloride. The process comprises preparation of prasugrel by... |
|
|
8937054 |
Liquid-fertilizer ready formulations of bifenthrin
Insecticidal compositions suitable for use in preparation of insecticidal liquid fertilizers are disclosed. The compositions include bifenthrin, a polymeric dispersant, a suspension agent, a... |
|
|
8933085 |
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
The present invention provides cyclobutyl substituted pyrrolopyrimidines and pyrrolopyridines of Formula I: wherein X, Y, Z, L, A, R5, n and m are defined above, as well as their compositions and... |
|
|
8921340 |
Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions
The present invention features the use of a synthetic triterpenoid to induce gene expression and differentiation of stem or progenitor cells in the treatment of bone/cartilage diseases or conditions. |
|
|
8900607 |
Clear, greaseless skin-care compositions
The present invention relates to compositions including anhydrous compositions which include dimethicone crosspolymer and/or dimethicone elastomer gum and one or more skin care products which may... |
|
|
8895035 |
Alkoxyimino derivative and pest control agent
The present invention provides a novel alkoxyimino derivative or a salt thereof, as well as to a pest control agent containing the derivative or salt thereof as an active ingredient, which shows... |
|
|
8883763 |
Use of isoquinolones for preparing drugs, novel isoquinolones and method for synthesising same
The use of isoquinolones for preparing drugs, including novel isoquinolones as well as their synthesis method. In particular, isoquinolone derivatives used in the treatment of pathological... |
|
|
8871210 |
Chemokine receptor antagonists and use thereof
The present invention relates to a compound represented by formula (I): wherein all symbols are as defined here, a salt thereof, a solvate thereof, or a prodrug thereof. The compound of the... |
|
|
8865682 |
Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation. |
|
|
8859618 |
Silicone gel-based compositions for wound healing and scar reduction
This invention is a composition comprising a cyclic siloxane, a silicone occlusive fluid, a silicone occlusive gel, and a silicone resin powder. The composition is useful for wound healing. |
|
|
8852615 |
Clear, greaseless skin-care compositions
The present invention relates to compositions including anhydrous compositions which include a dimethicone crosspolymer and/or dimethicone elastomer gum and one or more skin care products which... |
|
|
8846566 |
Composition for controlling plant diseases and method for controlling plant diseases
PROBLEM There are provided a composition for controlling plant diseases and a method for controlling plant diseases having excellent control effect for plant diseases.SOLUTIONA composition for... |
|
|
8835409 |
3-alkenyl-6-halo-4-aminopicolinates and their use as herbicides
3-Alkenyl-6-halo-4-aminopicolinic acids and their derivatives are potent herbicides demonstrating a broad spectrum of weed control. |
|
|
8822433 |
Complex combining an organic silicon derivative with hyaluronic and acid calibrated fragments, for preventive and repairing action of cutaneous damages
The invention concerns a complex based on an organic silicon derivative. The invention is characterized in that said derivative is combined, by weak bonds, with one or several hyaluronic acid... |
|
|
8821838 |
Nanoparticulate compositions for diagnostic imaging
The present invention provides a trialkoxysilane having structure I wherein R1 is independently at each occurrence a C1-C3 alkyl group; R3 is independently at each occurrence a hydrogen or a C1-C3... |
|
|
8778910 |
Concentrated lamellar liquid personal cleansing composition
The invention relates to concentrated liquid cleansing compositions in lamellar phase which possess a lotion-like appearance conveying signals of enhanced moisturization. The use of a specific... |
|
|
8772266 |
Fungicide pyrazole carboxamides derivates
The present invention relates to pyrazole carboxamides derivatives of formula (1) wherein Y represents CR5 or N, T represents S or O, X1 and X2 represent a chlorine or a fluorine atom, and Z1... |
|
|
8771642 |
Active particles for bio-analytical applications and methods for their preparation
Nanoparticles, which are luminescent and/or electroactive and/or suitable for MRI (magnetic resonance imaging and/or PET (positron emission tomography) applications, comprise a micelle, which has... |
|
|
8765719 |
Therapeutic drug for adult T-cell leukemia
An object is to provide a novel therapeutic drug for adult T-cell leukemia having an ATL cell specific antitumor effect. The therapeutic drug for adult T-cell leukemia according to the invention... |
|
|
8765782 |
Indole derivatives as selective androgen receptor modulators (SARMS)
The present invention is directed to novel indole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen... |
|
|
8765718 |
Cosmetic preparation comprising silicone
The present invention discloses a cosmetic preparation which comprises 20 mass % or more of an oil ingredient comprising the following components (A) and (B), and said oil ingredient comprising 50... |
|
|
8765734 |
Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
The present invention provides piperidin-4-yl azetidine derivatives, as well as their compositions and methods of use, that modulate the activity of Janus kinase 1 (JAK1) and are useful in the... |
|
|
8759323 |
Protein phosphatase inhibitor
Provided is a novel protein phosphatase inhibitor. The protein phosphatase inhibitor contains, as an active ingredient, a silicon compound represented by the following general formula (1) or a... |
|
|
8754146 |
Antimicrobial quaternary ammonium organosilane compositions
Antimicrobial granules comprise carrier particles agglomerated by a binding agent containing a quaternary ammonium organosilane. |
|
|
8748489 |
Solid pharmaceutical composition containing a combination of an intestinal motility regulating agent and an antiflatulent
This invention relates to a solid pharmaceutical composition that include a regulating agent of digestive and/or intestinal motility which has an agonist effect on peripheral μ, δ and κ opiate... |
|
|
8709457 |
Hydroxylated amide skin moisturizer
The invention relates to the cosmetic use, as a skin moisturizer, of a compound of formula (I): with (i) R1 and R2 represent a hydrogen atom or a C1-C6 alkyl group, or(ii) R1 and R2 can form,... |
|
|
8709747 |
Biphotonic photosensitizers, nanoparticles containing the same and their use as drugs
The invention relates to compounds of formula (I) whereinthe groups A and B represent independently from each other —CH═CH—, or —C≡C—,the terms t, u, v, w represent, independently from each other,... |
|
|
8697103 |
Alcoholic pump foam
An alcoholic foam composition, which can be dispensed as a foam via a pump-foam system contains a) at least 52 to ≦99 wt % of an alcohol or mixture of alcohols, b) a surfactant or a surfactant... |
|
|
8697673 |
Bicyclic pyridinones
Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I as defined herein. Corresponding pharmaceutical compositions,... |
|
|
8697101 |
Polysiloxane antimicrobials
Disclosed are oligo- or polysiloxanes, which are characterized by containing at least 3, for example 4-3000, Si atoms in the main chain, and wherein at least one thereof is contained in a moiety... |
|
|
8679572 |
Coated stent
A coated stent (20) for use in a medical procedure and methods of manufacturing the coated stent (20) are described. A stent component (30) has an expanded state in which an inner diameter (ds) of... |
|
|
8673881 |
Compositions and methods for the treatment of inflammation
The invention relates to novel resolvin compounds and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel resolvin compounds of the invention. |
|
|
8658568 |
6-amino-2-substituted-5-vinylsilylpyrimidine-4-carboxylic acids and esters and 4-amino-6-substituted-3-vinylsilylpyridine-2-carboxylic acids and esters as herbicides
6-Amino-2-substituted-5-vinylsilylpyrimidine-4-carboxylates and 4-amino-6-substituted-3-vinylsilylpyridine-picolinates and their amine and acid derivatives are potent herbicides demonstrating a... |
|
|
8642576 |
Heterocyclic CETP inhibitors
Compounds of formula Ia and Ib wherein A, B, C and R1 are described herein. |
|
|
8637489 |
Clear carrier compositions for lipophilic compounds, and method of treating keratinous substrates using such compositions
The present invention relates to a composition comprising: (a) at least one alkoxylated silicone acid;(b) at least one amino compound chosen from polyamines, alkoxylated polyamines, alkyl... |